Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Beijing Wantai Biological Pharmacy Enterprise Co stock

603392.SS
CNE100004090

Price

72.45
Today +/-
+0.08
Today %
+0.85 %

Beijing Wantai Biological Pharmacy Enterprise Co stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Beijing Wantai Biological Pharmacy Enterprise Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Beijing Wantai Biological Pharmacy Enterprise Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Beijing Wantai Biological Pharmacy Enterprise Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Beijing Wantai Biological Pharmacy Enterprise Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Beijing Wantai Biological Pharmacy Enterprise Co Stock Price History

DateBeijing Wantai Biological Pharmacy Enterprise Co Price
11/27/202472.45 undefined
11/26/202471.84 undefined
11/25/202472.72 undefined
11/22/202473.17 undefined
11/21/202473.93 undefined
11/20/202471.76 undefined
11/19/202472.14 undefined
11/18/202471.00 undefined
11/15/202472.16 undefined
11/14/202473.75 undefined
11/13/202475.25 undefined
11/12/202474.78 undefined
11/11/202475.00 undefined
11/8/202473.81 undefined
11/7/202475.13 undefined
11/6/202471.67 undefined
11/5/202472.98 undefined
11/4/202471.96 undefined
11/1/202472.50 undefined
10/31/202471.38 undefined
10/30/202471.89 undefined

Beijing Wantai Biological Pharmacy Enterprise Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Beijing Wantai Biological Pharmacy Enterprise Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Beijing Wantai Biological Pharmacy Enterprise Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Beijing Wantai Biological Pharmacy Enterprise Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Beijing Wantai Biological Pharmacy Enterprise Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Beijing Wantai Biological Pharmacy Enterprise Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Beijing Wantai Biological Pharmacy Enterprise Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Beijing Wantai Biological Pharmacy Enterprise Co’s growth potential.

Beijing Wantai Biological Pharmacy Enterprise Co Revenue, EBIT and net profit per share

DateBeijing Wantai Biological Pharmacy Enterprise Co RevenueBeijing Wantai Biological Pharmacy Enterprise Co EBITBeijing Wantai Biological Pharmacy Enterprise Co Net Income
2026e10.04 B undefined2.15 B undefined3.29 B undefined
2025e3.44 B undefined830.27 M undefined722.8 M undefined
2024e2.63 B undefined351.21 M undefined417.59 M undefined
20235.51 B undefined1.41 B undefined1.25 B undefined
202211.19 B undefined5.49 B undefined4.74 B undefined
20215.75 B undefined2.32 B undefined2.02 B undefined
20202.35 B undefined780 M undefined677 M undefined
20191.18 B undefined201.1 M undefined208.9 M undefined
2018982.7 M undefined157.1 M undefined293.1 M undefined
2017949.5 M undefined176.3 M undefined150.4 M undefined

Beijing Wantai Biological Pharmacy Enterprise Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (B)DOCUMENTS
20172018201920202021202220232024e2025e2026e
0.950.981.182.355.7511.195.512.633.4410.04
-3.4820.4798.99144.2794.52-50.74-52.2730.68192.23
69.0271.1870.5079.9985.2589.3582.00171.79131.4544.98
0.660.70.831.884.99.994.52000
0.150.290.210.682.024.741.250.420.723.29
-95.33-29.01225.48198.52134.29-73.66-66.5673.14356.23
----------
----------
0.510.530.550.591.231.251.26000
----------
Details

Keystats

ⓘ

Revenue and Growth

The Beijing Wantai Biological Pharmacy Enterprise Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Beijing Wantai Biological Pharmacy Enterprise Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (B)TOTAL CAPITAL (B)
2017201820192020202120222023
             
0.360.430.340.81.657.196.24
0.190.180.250.692.263.942.99
19.921.820.836.944.1165.8592.22
178.7218.6236.4400593.17869.14905.49
8.817.936.145.299.67111.4474.48
0.760.870.891.984.6512.1810.3
0.570.590.670.931.812.412.88
0.020.020.230.210.060.911.43
00000.0420.7750.02
253.9248.9242233.9295.13332.38642.74
4.6000000
40.480.1136.6151.4231.21372.05405.59
0.90.941.281.532.44.055.41
1.661.812.173.57.0516.2315.71
             
0.360.390.390.430.610.911.27
0.020.170.170.450.453.733.31
0.490.7911.673.417.918.25
0000000
0000000
0.881.351.562.554.4712.5412.83
86.674.485112.7193.46317.04299.87
4452.163.1103.5208.13310.13268.53
0.340.220.340.541.712.671.92
1000077.7235.45174.87173.08
000013.9313.7313.3
0.570.340.490.832.373.492.67
118.32121037.49120.92127.72
0000017.150
67.378.971.294.380.2441.3733.65
185.699.992.294.3117.73179.43161.37
0.760.440.580.922.483.662.83
1.641.792.143.486.9516.2115.66
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Beijing Wantai Biological Pharmacy Enterprise Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Beijing Wantai Biological Pharmacy Enterprise Co's financial health and stability.

Assets

Beijing Wantai Biological Pharmacy Enterprise Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Beijing Wantai Biological Pharmacy Enterprise Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Beijing Wantai Biological Pharmacy Enterprise Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Beijing Wantai Biological Pharmacy Enterprise Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (B)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201720182019202020212022
000000
000000
000000
-455-485-571-790-1,407-3,454
000000
000000
-76-86-99-145-295-1,164
0.150.210.270.471.684.13
-214-246-162-390-1,047-929
-301-352-198-295-1,014-3,513
-87-106-369533-2,583
000000
218-1970561625
000000
0.21-0.03-0.010.380.053.13
-0.010.17-00.3203.25
00-1-1-112-127
0.730.611.011.954.112.52
-67.7-37.8110.777.8634.163,202.68
000000

Beijing Wantai Biological Pharmacy Enterprise Co stock margins

The Beijing Wantai Biological Pharmacy Enterprise Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Beijing Wantai Biological Pharmacy Enterprise Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Beijing Wantai Biological Pharmacy Enterprise Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Beijing Wantai Biological Pharmacy Enterprise Co's sales revenue. A higher gross margin percentage indicates that the Beijing Wantai Biological Pharmacy Enterprise Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Beijing Wantai Biological Pharmacy Enterprise Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Beijing Wantai Biological Pharmacy Enterprise Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Beijing Wantai Biological Pharmacy Enterprise Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Beijing Wantai Biological Pharmacy Enterprise Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Beijing Wantai Biological Pharmacy Enterprise Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Beijing Wantai Biological Pharmacy Enterprise Co Margin History

Beijing Wantai Biological Pharmacy Enterprise Co Gross marginBeijing Wantai Biological Pharmacy Enterprise Co Profit marginBeijing Wantai Biological Pharmacy Enterprise Co EBIT marginBeijing Wantai Biological Pharmacy Enterprise Co Profit margin
2026e81.99 %21.37 %32.8 %
2025e81.99 %24.16 %21.03 %
2024e81.99 %13.35 %15.88 %
202381.99 %25.52 %22.64 %
202289.35 %49.06 %42.34 %
202185.26 %40.39 %35.15 %
202079.98 %33.13 %28.76 %
201970.48 %16.99 %17.65 %
201871.17 %15.99 %29.83 %
201769.08 %18.57 %15.84 %

Beijing Wantai Biological Pharmacy Enterprise Co Stock Sales Revenue, EBIT, Earnings per Share

The Beijing Wantai Biological Pharmacy Enterprise Co earnings per share therefore indicates how much revenue Beijing Wantai Biological Pharmacy Enterprise Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Beijing Wantai Biological Pharmacy Enterprise Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Beijing Wantai Biological Pharmacy Enterprise Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Beijing Wantai Biological Pharmacy Enterprise Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Beijing Wantai Biological Pharmacy Enterprise Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Beijing Wantai Biological Pharmacy Enterprise Co Revenue, EBIT and net profit per share

DateBeijing Wantai Biological Pharmacy Enterprise Co Sales per ShareBeijing Wantai Biological Pharmacy Enterprise Co EBIT per shareBeijing Wantai Biological Pharmacy Enterprise Co Earnings per Share
2026e7.94 undefined0 undefined2.61 undefined
2025e2.72 undefined0 undefined0.57 undefined
2024e2.08 undefined0 undefined0.33 undefined
20234.37 undefined1.12 undefined0.99 undefined
20228.96 undefined4.39 undefined3.79 undefined
20214.67 undefined1.88 undefined1.64 undefined
20204.02 undefined1.33 undefined1.16 undefined
20192.17 undefined0.37 undefined0.38 undefined
20181.87 undefined0.3 undefined0.56 undefined
20171.88 undefined0.35 undefined0.3 undefined

Beijing Wantai Biological Pharmacy Enterprise Co business model

Beijing Wantai Biological Pharmacy Enterprise Co is one of the most popular companies on Eulerpool.com.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Beijing Wantai Biological Pharmacy Enterprise Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Beijing Wantai Biological Pharmacy Enterprise Co historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Beijing Wantai Biological Pharmacy Enterprise Co shares outstanding

The number of shares was Beijing Wantai Biological Pharmacy Enterprise Co in 2023 — This indicates how many shares 1.26 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Beijing Wantai Biological Pharmacy Enterprise Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Beijing Wantai Biological Pharmacy Enterprise Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Beijing Wantai Biological Pharmacy Enterprise Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Beijing Wantai Biological Pharmacy Enterprise Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Beijing Wantai Biological Pharmacy Enterprise Co stock splits

In Beijing Wantai Biological Pharmacy Enterprise Co's history, there have been no stock splits.

Beijing Wantai Biological Pharmacy Enterprise Co dividend history and estimates

In 2023, Beijing Wantai Biological Pharmacy Enterprise Co paid a dividend amounting to 0.71 CNY. Dividend means that Beijing Wantai Biological Pharmacy Enterprise Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Beijing Wantai Biological Pharmacy Enterprise Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Beijing Wantai Biological Pharmacy Enterprise Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Beijing Wantai Biological Pharmacy Enterprise Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Beijing Wantai Biological Pharmacy Enterprise Co Dividend History

DateBeijing Wantai Biological Pharmacy Enterprise Co Dividend
2026e0.97 undefined
2025e0.98 undefined
2024e0.97 undefined
20230.71 undefined
20220.1 undefined
20210.13 undefined

Beijing Wantai Biological Pharmacy Enterprise Co dividend payout ratio

In 2023, Beijing Wantai Biological Pharmacy Enterprise Co had a payout ratio of 5.19%. The payout ratio indicates the percentage of the company's profits that Beijing Wantai Biological Pharmacy Enterprise Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Beijing Wantai Biological Pharmacy Enterprise Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Beijing Wantai Biological Pharmacy Enterprise Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Beijing Wantai Biological Pharmacy Enterprise Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Beijing Wantai Biological Pharmacy Enterprise Co Payout Ratio History

DateBeijing Wantai Biological Pharmacy Enterprise Co Payout ratio
2026e4.9 %
2025e4.32 %
2024e5.19 %
20235.19 %
20222.6 %
20217.78 %
20205.19 %
20195.19 %
20185.19 %
20175.19 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Beijing Wantai Biological Pharmacy Enterprise Co.

Beijing Wantai Biological Pharmacy Enterprise Co latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.11 0.01  (-95.54 %)2024 Q3
6/30/20240.18 0.11  (-37.39 %)2024 Q2
12/31/20230.99 -0.44  (-144.54 %)2023 Q4
9/30/20231.18 0.08  (-93.25 %)2023 Q3
6/30/20231.09 0.35  (-67.4 %)2023 Q2
1

Eulerpool ESG Scorecard© for the Beijing Wantai Biological Pharmacy Enterprise Co stock

Eulerpool World ESG Rating (EESG©)

24/ 100

🌱 Environment

25

👫 Social

31

🏛️ Governance

15

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Beijing Wantai Biological Pharmacy Enterprise Co shareholders

%
Name
Stocks
Change
Date
55.82201 % Yangshengtang Co., Ltd.705,807,92806/30/2024
17.71218 % Zhong (Shanshan)223,951,07106/30/2024
3.54691 % Qiu (Zixin)44,846,76009/30/2024
1.25705 % Ding (Jinglin)15,894,05706/30/2024
1.17881 % Hong (Weigang)14,904,81606/30/2024
0.82688 % Qiu (Mingjing)10,455,00006/30/2024
0.78434 % E Fund Management Co. Ltd.9,917,1001,969,9846/30/2024
0.76745 % Li (Shayan)9,703,56306/30/2024
0.59997 % Li (Yimin)7,585,93806/30/2024
0.49582 % China Merchants Fund Management Co. Ltd.6,269,128-94,8606/30/2024
1
2
3
4
5
...
10

Beijing Wantai Biological Pharmacy Enterprise Co Executives and Management Board

Mr. Zixin Qiu

(61)
Beijing Wantai Biological Pharmacy Enterprise Co Chairman of the Board (since 2021)
Compensation 2.25 M

Mr. Yimin Li

(66)
Beijing Wantai Biological Pharmacy Enterprise Co Chief Engineer
Compensation 1.53 M

Mr. Xiangzhong Ye

(56)
Beijing Wantai Biological Pharmacy Enterprise Co Deputy General Manager, Director (since 2018)
Compensation 1.45 M

Ms. Lingzhi Zhao

(60)
Beijing Wantai Biological Pharmacy Enterprise Co Deputy General Manager, Director (since 2017)
Compensation 1.33 M

Mr. Yiyong Zhao

(52)
Beijing Wantai Biological Pharmacy Enterprise Co Chief Financial Officer
Compensation 1.24 M
1
2
3

Beijing Wantai Biological Pharmacy Enterprise Co Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
GlaxoSmithKline Stock
GlaxoSmithKline
SupplierCustomer0,43-0,17-0,46-0,34-0,120,20
Sanofi Stock
Sanofi
SupplierCustomer-0,010,02-0,35-0,15-0,020,36
Eurobio-Scientific Stock
Eurobio-Scientific
SupplierCustomer-0,130,610,500,140,050,55
1

Most common questions regarding Beijing Wantai Biological Pharmacy Enterprise Co

What is the P/E ratio of Beijing Wantai Biological Pharmacy Enterprise Co 2024?

The Beijing Wantai Biological Pharmacy Enterprise Co P/E ratio is 218.65.

What is the P/S ratio of Beijing Wantai Biological Pharmacy Enterprise Co 2024?

The Beijing Wantai Biological Pharmacy Enterprise Co P/S ratio is 34.72.

What is the Quality Investing of Beijing Wantai Biological Pharmacy Enterprise Co?

The Quality Investing for Beijing Wantai Biological Pharmacy Enterprise Co is 3/10.

What is the revenue of Beijing Wantai Biological Pharmacy Enterprise Co 2024?

The expected Beijing Wantai Biological Pharmacy Enterprise Co revenue is 2.63 B CNY.

How high is the profit of Beijing Wantai Biological Pharmacy Enterprise Co 2024?

The expected Beijing Wantai Biological Pharmacy Enterprise Co profit is 417.59 M CNY.

What is the business model of Beijing Wantai Biological Pharmacy Enterprise Co

No history available for Beijing Wantai Biological Pharmacy Enterprise Co.

What is the Beijing Wantai Biological Pharmacy Enterprise Co dividend?

Beijing Wantai Biological Pharmacy Enterprise Co pays a dividend of 0.1 CNY distributed over payouts per year.

How often does Beijing Wantai Biological Pharmacy Enterprise Co pay dividends?

The dividend cannot currently be calculated for Beijing Wantai Biological Pharmacy Enterprise Co or the company does not pay out a dividend.

What is the Beijing Wantai Biological Pharmacy Enterprise Co ISIN?

The ISIN of Beijing Wantai Biological Pharmacy Enterprise Co is CNE100004090.

What is the Beijing Wantai Biological Pharmacy Enterprise Co ticker?

The ticker of Beijing Wantai Biological Pharmacy Enterprise Co is 603392.SS.

How much dividend does Beijing Wantai Biological Pharmacy Enterprise Co pay?

Over the past 12 months, Beijing Wantai Biological Pharmacy Enterprise Co paid a dividend of 0.71 CNY . This corresponds to a dividend yield of about 0.99 %. For the coming 12 months, Beijing Wantai Biological Pharmacy Enterprise Co is expected to pay a dividend of 0.98 CNY.

What is the dividend yield of Beijing Wantai Biological Pharmacy Enterprise Co?

The current dividend yield of Beijing Wantai Biological Pharmacy Enterprise Co is 0.99 %.

When does Beijing Wantai Biological Pharmacy Enterprise Co pay dividends?

Beijing Wantai Biological Pharmacy Enterprise Co pays a quarterly dividend. This is distributed in the months of June, May, July, July.

How secure is the dividend of Beijing Wantai Biological Pharmacy Enterprise Co?

Beijing Wantai Biological Pharmacy Enterprise Co paid dividends every year for the past 6 years.

What is the dividend of Beijing Wantai Biological Pharmacy Enterprise Co?

For the upcoming 12 months, dividends amounting to 0.98 CNY are expected. This corresponds to a dividend yield of 1.35 %.

In which sector is Beijing Wantai Biological Pharmacy Enterprise Co located?

Beijing Wantai Biological Pharmacy Enterprise Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Beijing Wantai Biological Pharmacy Enterprise Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Beijing Wantai Biological Pharmacy Enterprise Co from 6/3/2024 amounting to 0.32 CNY, you needed to have the stock in your portfolio before the ex-date on 6/3/2024.

When did Beijing Wantai Biological Pharmacy Enterprise Co pay the last dividend?

The last dividend was paid out on 6/3/2024.

What was the dividend of Beijing Wantai Biological Pharmacy Enterprise Co in the year 2023?

In the year 2023, Beijing Wantai Biological Pharmacy Enterprise Co distributed 0.099 CNY as dividends.

In which currency does Beijing Wantai Biological Pharmacy Enterprise Co pay out the dividend?

The dividends of Beijing Wantai Biological Pharmacy Enterprise Co are distributed in CNY.

All fundamentals about Beijing Wantai Biological Pharmacy Enterprise Co

Our stock analysis for Beijing Wantai Biological Pharmacy Enterprise Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Beijing Wantai Biological Pharmacy Enterprise Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.